{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T15:35:22Z","timestamp":1794065722890,"version":"4.8.0"},"reference-count":39,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"no funding associated"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychoactive Drugs"],"published-print":{"date-parts":[[2024,5,26]]},"DOI":"10.1080\/02791072.2023.2227960","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T21:45:00Z","timestamp":1688075100000},"page":"412-421","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Risk for Ecstasy Use Disorder and Other Substance Use Among International Users of Recreational Ecstasy\/Molly\/MDMA"],"prefix":"10.1080","volume":"56","author":[{"given":"Nancy A.","family":"Haug","sequence":"first","affiliation":[{"name":"Department of Psychology, Palo Alto University, Palo Alto, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Wadekar","sequence":"additional","affiliation":[{"name":"Department of Psychology, Palo Alto University, Palo Alto, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Barry","sequence":"additional","affiliation":[{"name":"Department of Psychology, Palo Alto University, Palo Alto, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sottile","sequence":"additional","affiliation":[{"name":"Department of Psychology, Palo Alto University, Palo Alto, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-022-00329-y"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2020.1837167"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2019.1574997"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11013-021-09764-z"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2014.901586"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/2050324517711069"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.09.009"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211015221"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.07.030"},{"issue":"2","key":"e_1_3_4_12_1","first-page":"547","article-title":"Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats","volume":"247","author":"Gold L. H.","year":"1988","unstructured":"Gold, L. H., G. F. Koob, and M. A. Geyer. 1988. Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. The Journal of Pharmacology and Experimental Therapeutics 247 (2):547\u201355. PMID: 2903234.","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106059939"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/002204260303300102"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.04.012"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2017.1335736"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bky051"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.4161\/23328940.2014.955433"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.02.697"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106397"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113888"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2016.1219373"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2020.1749262"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105048900"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2318"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.415"},{"key":"e_1_3_4_27_1","first-page":"273","article-title":"Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users","volume":"4","author":"Peroutka S. J.","year":"1988","unstructured":"Peroutka, S. J., H. Newman, and H. Harris. 1988. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 4:273\u201377.","journal-title":"Neuropsychopharmacology"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1037\/adb0000170"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106061515"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/14659891.2018.1436607"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117715596"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1037\/10248-005"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/16066359.2019.1622684"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2022.107494"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119897559"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.266"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2019.1618334"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.08.020"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2009.03.029"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550490802269064"}],"container-title":["Journal of Psychoactive Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02791072.2023.2227960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T23:03:33Z","timestamp":1719875013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/02791072.2023.2227960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5,26]]}},"alternative-id":["10.1080\/02791072.2023.2227960"],"URL":"https:\/\/doi.org\/10.1080\/02791072.2023.2227960","relation":{},"ISSN":["0279-1072","2159-9777"],"issn-type":[{"value":"0279-1072","type":"print"},{"value":"2159-9777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ujpd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}